X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (403) 403
Publication (33) 33
Book Chapter (4) 4
Magazine Article (4) 4
Newsletter (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (279) 279
spiramycin - therapeutic use (218) 218
female (204) 204
spiramycin (174) 174
anti-bacterial agents - therapeutic use (125) 125
male (123) 123
adult (117) 117
animals (115) 115
pregnancy (104) 104
infant, newborn (64) 64
toxoplasmosis - drug therapy (63) 63
index medicus (61) 61
pyrimethamine - therapeutic use (57) 57
middle aged (51) 51
toxoplasmosis, congenital - drug therapy (51) 51
drug therapy, combination (49) 49
toxoplasmosis (46) 46
congenital toxoplasmosis (42) 42
pharmacology & pharmacy (42) 42
child (41) 41
toxoplasmosis, congenital - prevention & control (40) 40
microbiology (39) 39
antibiotics (38) 38
infectious diseases (38) 38
treatment outcome (38) 38
coccidiostats - therapeutic use (37) 37
toxoplasmosis, congenital - diagnosis (37) 37
adolescent (36) 36
antiprotozoal agents - therapeutic use (36) 36
pregnancy complications, parasitic - drug therapy (36) 36
antibiotics, antitubercular (34) 34
cryptosporidiosis - drug therapy (34) 34
mice (33) 33
spiramycin - administration & dosage (33) 33
diagnosis (32) 32
dermatologic agents (31) 31
infection (31) 31
toxoplasmosis - diagnosis (30) 30
child, preschool (29) 29
infant (27) 27
infections (27) 27
azithromycin (26) 26
follow-up studies (26) 26
spiramycin - pharmacology (26) 26
sulfadiazine - therapeutic use (26) 26
anti-infective agents - therapeutic use (25) 25
erythromycin (25) 25
therapy (25) 25
toxoplasma - immunology (23) 23
acute disease (22) 22
aged (22) 22
pregnancy complications, parasitic - diagnosis (22) 22
spiramycin - adverse effects (22) 22
analysis (21) 21
immunology (21) 21
parasitology (21) 21
pediatrics (21) 21
prenatal diagnosis (21) 21
spiramycin - analogs & derivatives (21) 21
time factors (21) 21
anti-bacterial agents - pharmacology (20) 20
pyrimethamine (20) 20
toxoplasma - drug effects (20) 20
gondii infection (19) 19
macrolides (19) 19
pregnancy complications, infectious - drug therapy (19) 19
research article (19) 19
retrospective studies (19) 19
toxoplasma - isolation & purification (19) 19
antibacterial agents (18) 18
metronidazole - therapeutic use (18) 18
prospective studies (18) 18
toxoplasmosis - transmission (18) 18
aids (17) 17
anti-bacterial agents - administration & dosage (17) 17
antibodies, protozoan - blood (17) 17
health aspects (17) 17
obstetrics & gynecology (17) 17
polymerase chain reaction (17) 17
risk (17) 17
sulfadiazine (17) 17
toxoplasma gondii (17) 17
gondii (16) 16
infectious disease transmission, vertical - prevention & control (16) 16
leucomycins - therapeutic use (16) 16
polymerase-chain-reaction (16) 16
veterinary sciences (16) 16
chronic disease (15) 15
drug combinations (15) 15
erythromycin - therapeutic use (15) 15
periodontitis - drug therapy (15) 15
toxoplasmosis - complications (15) 15
toxoplasmosis, congenital - epidemiology (15) 15
anti-bacterial agents - analysis (14) 14
care and treatment (14) 14
infants (14) 14
medicine, general & internal (14) 14
spiramycin - pharmacokinetics (14) 14
toxoplasmosis, animal - drug therapy (14) 14
treatment (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (305) 305
French (52) 52
Japanese (12) 12
Russian (12) 12
Italian (11) 11
German (6) 6
Polish (5) 5
Spanish (5) 5
Chinese (4) 4
Romanian (3) 3
Czech (1) 1
Hebrew (1) 1
Korean (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0138204
No effective drug and definitive "gold standard" treatment for Toxoplasma gondii (T. gondii) infection has been available so far, though some medicines have... 
DIAGNOSIS | IN-VITRO | TRANSMISSION | SULFADIAZINE | PYRIMETHAMINE | ENCEPHALITIS | MULTIDISCIPLINARY SCIENCES | PRENATAL TREATMENT | SPIRAMYCIN | CONGENITAL TOXOPLASMOSIS | ATOVAQUONE | Pyrimethamine - therapeutic use | Toxoplasmosis - drug therapy | Acquired Immunodeficiency Syndrome - transmission | Spiramycin - therapeutic use | Humans | Anti-Infective Agents - therapeutic use | Sulfadiazine - therapeutic use | Male | Treatment Outcome | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Clindamycin - therapeutic use | Toxoplasmosis - parasitology | Pregnancy | Toxoplasmosis - complications | Azithromycin - therapeutic use | Female | Toxoplasma - drug effects | Acquired Immunodeficiency Syndrome - complications | Antiprotozoal Agents - therapeutic use | Drug Therapy, Combination | Infectious Disease Transmission, Vertical - prevention & control | Drugs | Medical research | Sulfadiazine | Encephalitis | Medicine, Experimental | Medicine, Chinese | Drug therapy | Health aspects | Therapy | Laboratories | Clindamycin | Azithromycin | Trimethoprim | Clinical trials | Systematic review | Biology | Infections | Parasites | Tropical diseases | Confidence intervals | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Acquired immune deficiency syndrome--AIDS | Search engines | Public health | Deoxyribonucleic acid--DNA | Protozoa | Pathogens | Spiramycin | Immunoglobulins | Congenital diseases | Statistical analysis | Pyrimethamine | Traditional Chinese medicine | Statistics | Conversion | Medicine | Scientific papers | Herbal medicine | Citation indexes | Disease transmission | Infectious diseases | Cysts | Sulfonamides | Womens health | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | DNA
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 08/2016, Volume 10, Issue 8, p. e0004892
Purpose To assess the impact of intensive antifolate treatment, followed by secondary antifolate prophylaxis (A-SP) on the recurrence rate of toxoplasmic... 
SULFADIAZINE | THERAPY | PROGNOSIS | OCULAR TOXOPLASMOSIS | RANDOMIZED-TRIAL | PATTERNS | INTERMITTENT TRIMETHOPRIM/SULFAMETHOXAZOLE TREATMENT | AZITHROMYCIN | OUTBREAK | EPIDEMIOLOGY | PARASITOLOGY | TROPICAL MEDICINE | Recurrence | Folic Acid Antagonists - administration & dosage | Spiramycin - therapeutic use | Humans | Middle Aged | Spiramycin - administration & dosage | Sulfadoxine - administration & dosage | Male | Coccidiostats - therapeutic use | Secondary Prevention - methods | Toxoplasmosis, Ocular - prevention & control | Folic Acid Antagonists - therapeutic use | Young Adult | Pyrimethamine - administration & dosage | Sulfadoxine - therapeutic use | Aged, 80 and over | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Drug Therapy, Combination | Pyrimethamine - therapeutic use | Prednisone - administration & dosage | Drug Administration Schedule | Medical Records | Coccidiostats - administration & dosage | Treatment Outcome | Toxoplasmosis, Ocular - etiology | Adolescent | Toxoplasmosis, Ocular - parasitology | Aged | Toxoplasmosis, Ocular - drug therapy | Prednisone - therapeutic use | Prevention | Relapse | Patient outcomes | Uveitis | Antimalarials | Dosage and administration | Drug therapy | Diseases | Studies | Infectious diseases | Antibiotics | Funding | Infections | Multivariate analysis | Drug dosages | Patients
Journal Article
Experimental Parasitology, ISSN 0014-4894, 06/2016, Volume 165, pp. 95 - 102
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2008, Volume 47, Issue 4, pp. 554 - 566
Journal Article
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2010, Volume 203, Issue 6, pp. 552.e1 - 552.e6
Journal Article
International Journal for Parasitology: Drugs and Drug Resistance, ISSN 2211-3207, 12/2015, Volume 5, Issue 3, pp. 185 - 190
Journal Article
Placenta, ISSN 0143-4004, 2009, Volume 30, Issue 10, pp. 884 - 890
Abstract Toxoplasma gondii infection during pregnancy may cause severe consequences to the embryo. Current toxoplasmosis treatment for pregnant women is based... 
Internal Medicine | Obstetrics and Gynecology | Calomys callosus | Congenital toxoplasmosis | Treatment | Azithromycin | DIHYDROARTEMISININ | TOXICITY | DEVELOPMENTAL BIOLOGY | COMBINATION | PREGNANCY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | SPIRAMYCIN | TARGETS | INFECTION | PARASITE | ARTESUNATE | Immunohistochemistry | Toxoplasma - immunology | Spiramycin - therapeutic use | Plant Extracts - pharmacology | Sulfadiazine - therapeutic use | Embryo, Mammalian - parasitology | Spiramycin - pharmacology | Pyrimethamine - pharmacology | Toxoplasmosis, Congenital - transmission | Embryo, Mammalian - chemistry | Sulfadiazine - pharmacology | DNA, Protozoan - analysis | Polymerase Chain Reaction | Antibodies - immunology | Female | Leucovorin - therapeutic use | Placenta - chemistry | Drug Therapy, Combination | Pyrimethamine - therapeutic use | Toxoplasma - isolation & purification | Toxoplasmosis, Congenital - drug therapy | Artemisia annua - chemistry | Azithromycin - pharmacology | Pregnancy | Sigmodontinae - parasitology | Animals | Azithromycin - therapeutic use | Toxoplasmosis, Congenital - parasitology | Antibodies - blood | Mice | Placenta - parasitology | Infectious Disease Transmission, Vertical - prevention & control | Leucovorin - pharmacology | Plant Extracts - therapeutic use | Genetic disorders | Pregnant women | Analysis | Drug therapy, Combination | Antibacterial agents | Index Medicus
Journal Article